MeitY Startup Hub onboards MergerDomo to strengthen start-up ecosystem in India
Posted By - Investment Banker
A pure play branded generic marketing pharma company headquartered in Delhi with a pan India sales team of 300 medical reps with strong presence in north & east India selling brands across multiple therapeutic segments including Orthopedics with an expected turnover of Rs. 48 crores is looking for a strategic exit.
Deal Size
INR 65 - 70 Cr
Motives For Sellout
N/A
Industry
Pharmaceuticals
Sub-Industry
Generic Pharmaceuticals
Industry
Pharmaceuticals
Sub-Industry
Generic Pharmaceuticals
Division
Division`s Buyers/Customers
Justification
N/D
Justification
N/D
| 2017 (in Cr) | 2018 (in Cr) | 2019 (in Cr) | 2020 (in Cr) | ||
|---|---|---|---|---|---|
| Sales | N.D | INR 42 Cr | INR 48 Cr | N.D | |
| EBITDA | N.D | N.D | |||
| PAT | N.D | N.D | |||
| TOTAL DEBT | N.D | N.D | |||
If you are interested to connect with this party, please send an Expression of Interest and receive Information Memo to take this opportunity further
